The Life Raft Group is committed to enhancing the survival and quality of life for people living with Gastrointestinal Stromal Tumor (GIST), and other rare diseases, through patient-powered research, education and empowerment, and global advocacy efforts.
Other Programs Supported by The Life Raft Group:
PATIENT
Leverage patient perspective to drive innovative solutions in cancer research.
POWERED
Educate and empower patients to take a larger role in their care.
SCIENCE
Accelerate research outcomes through collaborative efforts.
FOR LIFE
Increase access to effective treatments worldwide.
Real World Evidence In Action
Traditional models for cancer research have resulted in many breakthrough treatments for patients, but it is not enough. The LRG’s approach to GIST research through real world evidence, relies on timely, accurate data from the patient’s perspective, with patient survival as the primary objective.
RECENT LRG DATA
Did you know that GIST is actually a family of cancers? Learn more about the science of GIST.
Update your Patient Registry Info.
Join The Life Raft Group.
Current GIST Clinical Trials.
Search the GIST Specialist Database.
Dr. Monica Anderson
Diagnosed in 2012 with Adult GIST.
Bella Rocco
Diagnosed in 2009 with Pediatric
(SDH-deficient) GIST.
HELP US SAVE LIVES
The Life Raft Group is a community and it is up to all of us to make a difference. There are many ways to help. We always need patient tissue and data in our GIST patient registry. Volunteering your time or making a monetary donation also helps us drive research forward and save lives.
News
Cellular origin of GIST from the “good” cells’ perspective
The main functions of the gastrointestinal tract are to secrete digestive juices, break down food components, absorb nutrients, reclaim water and excrete waste, which are performed by the mucosal lining of the gut...
GDOL Update: Speakers Announced
In addition to sharing hope and friendship, attendees will learn important facts about their cancer, prevailing treatment options, tests as indicators for treatment surveillance, and coping with dietary changes and side-effects of treatment.
LRG mourns the loss of a great friend, Jeroen Pit
Jeroen Pit, who passed away on February 6, was not a man to sit idly by and he certainly did not lose his battle with GIST without a terrible fight. After diagnosis, Jeroen and his devoted wife Emilie, immediately sought after cutting-edge GIST research and came across the Life Raft Group.
Retired horse trainer seeks to “Harness a Cure” through Dover Downs fundraiser
Twelve years ago, Life Rafter Bobby Kinsey began his own battle against GIST. Since then, he has helped countless people with GIST across the world. Most of you know Bobby as an LRG member who posts advice and words of encouragement in our email community. Now, Bobby has decided that he wants to do more to help fight this cancer.
GISTer’s daughter holds third annual ball for GIST
GIST has had a profound impact on my life even though I am not a patient myself. My father, Mark Becker, bravely fought his battle with GIST for 12 years before he died in 2009. Research and clinical trials are the two things that kept my dad alive long enough to see both of his daughters graduate high school and college, get married and have children.
Thank you for your support!
The Life Raft Group wishes to thank all of our members who participated in this year’s Holiday Campaign. Though it is still underway (look for final results in the next newsletter), this important campaign has raised over $47,000 to support our patient education & support, advocacy, and research to find a cure GIST.
LRG introduces GIST Day of Learning in Miami
The Life Raft Group is launching a new program called GIST Day of Learning. In response to the requests of previous attendees of [...]
Pfizer to open clinical trial for young patients with GIST
A new phase I/II clinical trial will soon be opening for pediatric and young adults with GIST. This trial will be testing Sutent (sunitinib), the currently approved second-line treatment for GIST, in young patients. At the current time, the optimal dose for Sutent is not known for pediatric patients. This trial will help assess the safety and tolerability of Sutent in young patients.
Keep up with the latest news, events, and opportunities to help.
To contact The Life Raft Group, please call 973-837-9092
PARTNERS & AFFILIATIONS
